Skip to content
Seqlense EUR-Lex

2014/514/EU: Commission Implementing Decision of 31 July 2014 authorising laboratories in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2014) 5352) Text with EEA relevance

CELEX
32014D0514
Document type
DEC_IMPL
Sector
Legislation
Date of document
2014-07-31
In force since
2014-08-15
Status
In force

Text

Article-level text, parsed from the formex manifestation.

Article 1

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: (a) KBNP, INC 235-9, Chusa-ro, Sinam-myeon Yesan-gun, Chungcheongnam-do Republic of Korea (b) Komipharm International Co. Ltd 17 Gyeongje-ro, Siheung-si, Gyeonggi-do, 429-848 Republic of Korea

Article 2

This Decision shall apply from 15 August 2014.

Article 3

This Decision is addressed to the Member States.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions